Inventor · disambiguated record
David J. Hackam
Also filed as: HACKAM DAVID · HACKAM DAVID J · HACKAM DAVID JOEL
13 granted patents·7 pending applications·95 citations·filing 2008–2025
90Inventor score
Files withUNIV JOHNS HOPKINS7UNIV OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION5HACKAM DAVID J3UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION3UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHTER EDUCATION1
Top patents by PatentIndex Score
20 records- 0192US8188058B2Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disordersHACKAM DAVID J·Filed 2008·Granted May 29, 2012·53 cites·3 claims
- 0291US9072760B2TLR4 inhibitors for the treatment of human infectious and inflammatory disordersUNIV PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2013·Granted Jul 7, 2015·10 cites·26 claims
- 0391US8518903B2Use of toll-like receptor-9 agonistsHACKAM DAVID J·Filed 2011·Granted Aug 27, 2013·10 cites·4 claims
- 0487US8518905B2Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disordersHACKAM DAVID J·Filed 2012·Granted Aug 27, 2013·15 cites·2 claims
- 0585US9532999B2TLR4 inhibitors for the treatment of human infectious and inflammatory disordersUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2015·Granted Jan 3, 2017·2 cites·13 claims
- 0677US11458141B2Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Oct 4, 2022·1 cites·9 claims
- 0777US9549980B2Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonistsUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHTER EDUCATION·Filed 2013·Granted Jan 24, 2017·2 cites·5 claims
- 0873US10933077B2TLR4 inhibitors for the treatment of human infectious and inflammatory disordersUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2019·Granted Mar 2, 2021·0 cites·11 claims
- 0973US9562066B2Oral therapy of necrotizing enterocolitisUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2013·Granted Feb 7, 2017·2 cites·6 claims
- 1070US2021308162A1Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disordersUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2021·Application pending·0 cites
- 1165US10300083B2TLR4 inhibitors for the treatment of human infectious and inflammatory disordersUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2016·Granted May 28, 2019·0 cites·18 claims
- 1265US2022080056A1Dendrimer compositions and use in treatment of necrotizing enterocolitis and other gastrointestinal disordersUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1364US10668092B2Compositions and methods for treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2018·Granted Jun 2, 2020·0 cites·21 claims
- 1463US11413299B2Compositions and methods for treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2020·Granted Aug 16, 2022·0 cites·16 claims
- 1555US10172848B2Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel diseaseUNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION·Filed 2013·Granted Jan 8, 2019·0 cites·15 claims
- 1652US2025154188A1C-glycosides as anti-inflammatory agentsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2025·Application pending·0 cites
- 1751US2019070168A1Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel diseaseUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2018·Application pending·0 cites
- 1851US2023357261A1Aryl hydrocarbon receptor ligands and their analogues for the prevention and treatment of inflammatory disordersUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1948US2022079935A1Compounds and treatments that enhance enteric nervous system functionUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2045US2017119897A1Dendrimer compositions and use in treatment of necrotizing enterocolitis and other gastrointestinal disordersUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David J. Hackam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →